Table 4.
Unweighted prevalence, % (95% CI) | Weighted prevalence, % | ||||
---|---|---|---|---|---|
n | Model 1a | Model 2b | Model 1a | Model 2b | |
Overall | 3364 | 5.8 (5.1–6.6) | 14.3 (13.2–15.5) | 4.7 | 11.0 |
By gender | |||||
Female | 1822 | 7.1 (6.0–8.4) | 17.5 (15.8–19.3) | 5.6 | 13.1 |
Male | 1542 | 4.2 (3.3–5.3) | 10.5 (9.1–12.1) | 3.7 | 8.8 |
By age groups | |||||
18–29 years | 424 | 0.7 (0.2–2.1) | 2.4 (1.3–4.3) | 0.8 | 1.6 |
30–39 years | 465 | 1.3 (0.6–2.8) | 7.5 (5.5–10.3) | 0.6 | 5.7 |
40–49 years | 828 | 4.3 (3.2–6.0) | 12.1 (10.0–14.5) | 4.4 | 9.7 |
50–59 years | 830 | 7.5 (5.9–9.5) | 18.3 (15.8–21.1) | 6.4 | 15.7 |
60–69 years | 527 | 9.5 (7.3–12.3) | 21.3 (18.0–24.9) | 8.7 | 18.4 |
≥70 years | 290 | 13.1 (9.7–17.5) | 24.8 (20.2–30.1) | 10.8 | 21.5 |
By age categories | |||||
<60 years | 2547 | 4.2 (3.5–5.1) | 11.7 (10.5–13.0) | 3.3 | 8.6 |
≥60 years | 817 | 10.8 (8.8–13.1) | 22.5 (19.8–25.5) | 9.5 | 19.7 |
By ethnicity and age groups | |||||
Chinese | |||||
Total | 1989 | 5.1 (4.2–6.1) | 10.9 (9.6–12.3) | 4.3 | 9.3 |
<40 years | 450 | 0.9 (0.3–2.3) | 2.9 (1.7–4.9) | 0.7 | 2.6 |
40–59 years | 967 | 4.7 (3.5–6.2) | 10.5 (8.7–12.5) | 4.9 | 10.5 |
≥60 years | 572 | 9.1 (7.0–11.7) | 17.8 (14.9–21.9) | 8.4 | 16.7 |
Malay | |||||
Total | 746 | 5.2 (3.8–7.1) | 18.5 (15.9–21.4) | 4.8 | 17.7 |
<40 years | 243 | 0.8 (0.2–3.0) | 6.6 (4.1–10.4) | 0.5 | 5.9 |
40–59 years | 381 | 5.8 (3.8–8.6) | 22.6 (18.7–27.0) | 5.3 | 20.8 |
≥60 years | 122 | 12.3 (7.6–19.3) | 29.5 (22.1–38.1) | 12.0 | 33.6 |
Indian | |||||
Total | 456 | 10.1 (7.6–13.2) | 23.0 (19.4–27.1) | 9.2 | 20.3 |
<40 years | 147 | 2.0 (0.7–5.8) | 9.5 (5.8–15.4) | 1.2 | 9.1 |
40–59 years | 222 | 12.2 (8.5–17.1) | 25.2 (20.0–31.3) | 11.5 | 23.9 |
≥60 years | 87 | 18.4 (11.6–27.8) | 40.2 (30.6–50.7) | 19.6 | 35.5 |
Model 1 = algorithm 3 of Instrument 3, sensitivity 0.44, specificity 0.95 for symptomatic knee osteoarthritis.
Model 2 = algorithm 3A of Instrument 3, sensitivity 0.62 and specificity 0.87 for symptomatic knee osteoarthritis.